NM_000292.3:c.3599_3601delTTT
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4_SupportingPP5_Moderate
The NM_000292.3(PHKA2):c.3599_3601delTTT(p.Phe1200del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000292.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.3599_3601delTTT variant in the PHKA2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The c.3599_3601delTTT variant is an in-frame deletion that results in the loss of a single Phenylalanine residue, denoted p.Phe1200del. The residue removed by this deletion is conserved across species. In silico analysis predicts this deletion is probably damaging to the protein structure/function. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.3599_3601delTTT as a likely pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at